Clinical trial
Oral Fecal Microbiota Transplant Capsules for Decolonization of Carbapenem-resistant Enterobacteriaceae: a Double-blind Randomized Controlled Trial
NCT05981430 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Oral Fecal Microbiota Transplant Capsules for Decolonization of Carbapenem-resistant Enterobacteriaceae: a Double-blind Randomized Controlled Trial
- Lead sponsor
- The University of Hong Kong
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- June 30, 2028
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
carbapenem-resistant enterobacteriaceae infection, fecal microbiota transplantation